Breast Cancer is the cell mutation that takes place in the genes that regulate cell growth which causes formation of lumps or tumors in the breast cells. The cancer is formed in either the lobule, the gland that produces milk or the ducts of the breast, which are the pathways that bring the milk from the glans to the nipple. The cancerous cells can also be formed in the fatty tissues or even the fibrous connective tissues within the breast. There are mainly four types of cancers namely, Ductal carcinoma in situ, Lobular carcinoma in situ, invasive ductal carcinoma, and invasive lobular carcinoma. The early detection is a necessity to prevent the spread of the cancer and hence, the growth of the breast cancer screening industry is expected in the forecast period.
COVID-19 scenario analysis:
The outbreak of the pandemic resulted into a complete lockout situation which led to the halt in the production and manufacturing of various products leading to the global economic crisis in every sector. However, increase in the demand for R&D in the diagnostic tests for the COVID-19 would help the key leaders to focus on the investments for the innovation. The healthcare sector involves R&D of the diagnostic tests, which is expected to propel in the current scenario. The current unavailability of specific COVID-19 diagnostic tests presented lucrative opportunities for diagnostic manufacturers to bring up their COVID-19 diagnostic kits. Many leading players as well as some start-ups from various countries utilized this opportunity and introduced COVID-19 diagnostics kits into local as well as global market. These players achieved edge over other diagnostics players capitalizing the opportunity from demand for COVID-19 diagnostic tests, which, in turn, helps them in maintaining their revenues in such a crisis.
Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis
The key factors that are anticipated to boost the market include rise in incidences of breast cancer and increase in the adoption of unhealthy lifestyle leading to breast cancer. Furthermore, the steep hike in the awareness for the pre-diagnostics of the various types of cancer would help the industry to flourish. The surge in the technological advancements which can be used for the screening of breast cancer are anticipated to help the market grow in the forecast period. However, the higher exposure to the radiation during the screening may hamper the growth in the near future.
The global breast cancer screening test market trends are as follows:
New product launches to flourish the market
The rise in the technological advancements and hence, the product launches declared by the key market leaders would help the market witness growth in the coming years. For instance, in 2017, FUJIFILM Medical Systems Inc. announced the launch of Digital Breast Tomosynthesis (DBT). The software upgrade is designed for its ASPIRE Cristalle digital mammography system. DBT had recently gained premarket approval (PMA) from the U.S. Food and Drug Administration (FDA).
The growth in the R&D carried out by the various market players leading them to launch new products is expected to boost the market in the coming years. For instance, in 2018, Philips Healthcare launched ElastQ Imaging shear wave and strain elastography. It also innovated to have an ability to reveal better definitive information on tissue stiffness in the breast.
Surge in incidences of AMD to boost the market
The increase in the incidences and prevalence of the breast cancer is expected to boost in the coming years. In 2019, according to the American Cancer Society, it is stated that about 1 in 8 women (13%) are expected to be diagnosed with invasive breast cancer in their lifetime. Furthermore, approximately 1 in every 39 women (3%) is expected to die from breast cancer. The growing concern for the pre-diagnostics of the breast cancer would help the industry in the future.
In addition, in 2018, according to the American Cancer Society, it was stated that one-third of postmenopausal breast cancers are related to possibly modifiable factors. The major factors affecting include complete physical inactivity, postmenopausal obesity due to hormonal imbalances. The use of progestin menopausal hormones, combined with the alcohol consumption, and not breastfeeding would trigger the incidence of breast cancer. The growth in the number of individuals adopting unhealthy lifestyle and usage of the medication that can cause breast cancer is expected to boost the market during the forecast period.
Key benefits of the report:
- This study presents the analytical depiction of the global breast cancer screening test industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global market share.
- The current market is quantitatively analyzed to highlight the global market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed global breast cancer screening test market analysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in the breast cancer screening test market research report:
- Who are the leading market players active in the breast cancer screening test market?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities in the market?
- What are the projections for the future that would help in tasking further strategic steps?
Breast Cancer Screening Test Market Report Highlights
| Aspects | Details |
 By Type |
|
 By End user |
|
 By Region |
|
 Key Market Players | Shimadzu Corporation, Delphinus, Micrima Limited, Siemens Healthineers, Aurora Imaging Technology, Inc, Hologic, Inc, Toshiba Medical Systems Corporation, Philips Healthcar, GE Healthcare, Fujifilm Holdings Corporation |
 Other Players | Medical Technologies, Inc. |
Loading Table Of Content...
